12.20.16
With its first six months on the market, the BioStamp Research Connect System has made strong market penetration in academic research communities as a primary tool in ongoing studies. The system’s broad applicability has positioned it as a resource for a variety of use cases in physiological data analysis and discovery.
The objective output and location-agnostic sensing capabilities of the System have inspired companies ready to embrace the insights wearables can offer. Seven of the top 15 pharmaceutical companies in the world are evaluating exploratory applications using the BioStampRC System and paving the way for clinical trial innovation. Pfizer is one of the customers working with the BioStampRC System.
Universities across the country, including MC10 partners the University of Rochester and the University of Illinois at Urbana-Champaign, have integrated the BioStampRC System into their biometric research investigations. The institutions are combining metrics from the BioStampRC System with their own analysis to further their explorations in neurology.
The objective output and location-agnostic sensing capabilities of the System have inspired companies ready to embrace the insights wearables can offer. Seven of the top 15 pharmaceutical companies in the world are evaluating exploratory applications using the BioStampRC System and paving the way for clinical trial innovation. Pfizer is one of the customers working with the BioStampRC System.
Universities across the country, including MC10 partners the University of Rochester and the University of Illinois at Urbana-Champaign, have integrated the BioStampRC System into their biometric research investigations. The institutions are combining metrics from the BioStampRC System with their own analysis to further their explorations in neurology.
